Cano Health Inc
NYSE:CANO
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
US |
Cano Health Inc
NYSE:CANO
|
1.3m USD | -2.8 | ||
US |
HCA Healthcare Inc
NYSE:HCA
|
83.2B USD | 9.3 | ||
SA |
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
110.3B SAR | 46.8 | ||
CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
122.3B CNY | 24.2 | |
ZA |
N
|
Netcare Ltd
JSE:NTC
|
15.3B Zac | 0 | |
ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
15.3B Zac | 0 | |
BR |
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
67.1B BRL | 9.9 | ||
TH |
B
|
Bangkok Dusit Medical Services PCL
SET:BDMS
|
464.8B THB | 19 | |
US |
Tenet Healthcare Corp
NYSE:THC
|
12.1B USD | 5.8 | ||
MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
55.5B MYR | 10.8 | |
US |
Universal Health Services Inc
NYSE:UHS
|
11.4B USD | 8.6 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.